ALZHEIMER DISEASE 6, LATE-ONSET

Known as: AD6, Alzheimer Disease 6 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1975-2017
01219752017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
 
  • figure 1
Is this relevant?
2006
2006
The purpose of this study was to improve the stability of cloricromene (AD6) in ophthalmic formulations and its drug availability… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
Cloricromene (AD6), an anti-ischemic drug, is rapidly metabolised into a stable and active metabolite (cloricromene acid, AD6… (More)
Is this relevant?
2004
2004
To investigate the expression of Bcl-2 and Bcl-xl gene in sensitive (A2780) and drug-resistance (AD6) human ovarian cancer cell… (More)
  • figure 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
1996
1996
We previously reported that two surface-exposed high-molecular-weight proteins, HMW1 and HMW2, expressed by a prototypic strain… (More)
Is this relevant?
1981
1981
A new method is presented for the quantitative analysis of intercellular adhesive specificity. In this assay, two cell types are… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
1981
1981
The cell-to-substrate contacts of the adhesion-defective mutant, AD6, have been examined by interference reflexion microscopy and… (More)
  • table 1
  • figure 8
  • table 2
  • table 3
Is this relevant?
1978
1978
Using tunicamycin, we have investigated the role of glycosylation in the biosynthesis, processing and turnover of CSP, the major… (More)
Is this relevant?
1977
1977
AD6, a mutant derived from 3T3 Balb/c cells, is characterized by low adhesion to substratum, round shape, increase in surface… (More)
Is this relevant?
1977
1977
We hve reported the isolation and preliminary biochemical characterization of two mutants of mouse fibroblasts selected for a… (More)
Is this relevant?